Eileen Smith was appointed chair of the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope.
An $18 million commitment from the Simms/Mann Family Foundation, led by Victoria Mann Simms and Ronald Simms, will support UCLA's expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.
Atefeh “Atti” Riazi was named chief information officer of Memorial Sloan Kettering Cancer Center.
Usama Gergis joined The Sidney Kimmel Cancer Center–Jefferson Health as director of the Bone Marrow Transplant and Immune Cellular Therapy Program and professor in the Department of Medical Oncology, Division of Hematological Malignancies.
Ragini Kudchadkar, a medical oncologist and melanoma specialist at Winship Cancer Institute of Emory University, was named chair of the Clinical and Translational Review Committee, the group responsible for scientifically reviewing all proposed cancer clinical trials at Winship.
The Cancer Prevention and Research Institute of Texas recruited its 200th CPRIT Scholar to Texas.
The American Society of Clinical Oncology released a position statement, “Block Grants in Medicaid & Their Impact on Cancer Care,” summarizing the society's concerns about the potential negative impact that recent proposals to establish annual limits on federal funding for Medicaid--or block grants--could have on patients with cancer.
The National Brain Tumor Society is providing $200,000 to Oncoceutics to support a phase II clinical trial of ONC201, the first imipridone dopamine receptor D2 antagonist, in a molecular subset of high grade gliomas.
The Foundation for the NIH has opened nominations for its 2020 Trailblazer Prize for clinician-scientists, recognizing the outstanding contributions of early-career clinician-scientists whose work has the potential to lead to innovations in patient care—or has already done so.
Oliver Bogler was named director of the NCI Center for Cancer Training. He will focus on NCI training and career development programs to develop cancer research through a scientifically-integrated approach.
